Top Life Science AI Solutions Providers in APAC

We’re thrilled to present the Top Life Science AI Solutions Providers in APAC, a prestigious honor recognizing the industry’s game-changers. These exceptional businesses were nominated by our subscribers based on impeccable reputation and the trust these companies have garnered from our valued subscribers. After an intense selection process—led by C-level executives, industry pioneers and our expert editorial team—only the best have made the cut. These companies have been selected as recipients of the award, celebrating their leadership and innovation.

Nominate a Company ×

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

Enter the code below: *

Can't read the image? click here to refresh

Submit

Thank You!

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

Top Life Science AI Solutions Providers in APAC

Click here to Nominate a Company

AnHorn Medicines
AnHorn Medicines applies its AIMCADD platform to AI-assisted drug discovery, supporting the development of therapies for challenging diseases. Its work combines computational design with targeted protein degradation, including BIGPRO protein degraders and novel E3 binders across oncology, neurodegeneration, age-related disease and prescription aesthetics.

Great Bay Bio
Great Bay Bio integrates artificial intelligence, big data mining and automation across antibody design, sequence optimization, cell line development and culture media development. Its AlfaBodY, AlfaDAX, AlfaCell and AlfaMedX platforms support biopharmaceutical teams from molecule creation through bioprocess development and manufacturing preparation.

MindRank
MindRank applies machine learning, biology and chemistry to small-molecule drug discovery. Its AI platform supports target identification, molecular generation and compound optimization, enabling the company to advance proprietary programs while working with pharmaceutical partners on drug candidates for complex diseases.

NeuroXess
NeuroXess develops implantable flexible brain-computer interface systems combining proprietary hardware, algorithms and XessOS software. Its platform applies AI-powered neural decoding to restore movement and communication capabilities, enabling users with severe neurological conditions to control computers, smart devices and assistive equipment through thought.

TrialKey
TrialKey uses AI-driven biostatistical simulation to assess clinical trial designs before patient enrollment. Its platform models eligibility criteria, endpoints, costs and protocol variables, helping sponsors compare scenarios, predict success probability, optimize trial structures and monitor execution risks through evidence-based decision support.

Life Science AI News